Abstract

ObjectivesLow grade serous (LGS) ovarian cancer (OC) patients with recurrent peritoneal metastases (PM) have poor prognoses due to inherently chemo-resistant tumors. PIPAC is an intraperitoneal (IP) treatment that intensifies chemotherapy...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call